134 related articles for article (PubMed ID: 9636530)
1. Therapy of hyperlipidemia with lovastatin in kidney transplant patients on cyclosporine A immunosuppression: three-year experience.
Kandus A; Kovac D; Cerne D; Koselj M; Kaplan-Pavlovcic S; Buturović J; Ponikvar R; Kveder R; Lindic J; Bren AF
Transplant Proc; 1998 Jun; 30(4):1307-9. PubMed ID: 9636530
[No Abstract] [Full Text] [Related]
2. Comparison of pravastatin and lovastatin in renal transplant patients receiving cyclosporine.
Kliem V; Wanner C; Eisenhauer T; Olbricht CJ; Doll R; Boddaert M; O'Grady P; Krekler M; Mangold B; Christians U
Transplant Proc; 1996 Dec; 28(6):3126-8. PubMed ID: 8962211
[No Abstract] [Full Text] [Related]
3. Lovastatin treatment of hyperlipidemia in kidney transplant recipients on cyclosporine immunosuppression.
Kandus A; Kovac D; Koselj M; Kveder R; Bren AF
Transplant Proc; 1994 Oct; 26(5):2642-3. PubMed ID: 7940824
[No Abstract] [Full Text] [Related]
4. Lipid-lowering long-term effects of six different statins in hypercholesterolemic renal transplant patients under cyclosporine immunosuppression.
Martínez-Castelao A; Grinyó JM; Gil-Vernet S; Serón D; Castiñeiras MJ; Ramos R; Alsina J
Transplant Proc; 2002 Feb; 34(1):398-400. PubMed ID: 11959343
[No Abstract] [Full Text] [Related]
5. A crossover comparison of the efficacy and safety of lovastatin and gemfibrozil in the treatment of hyperlipidemic organ transplant recipients.
Hanes DS; Nicholson PG; Raval DD; Hooper FL; Behrens MT; Weir MR
Am J Ther; 1997; 4(2-3):85-91. PubMed ID: 10423597
[TBL] [Abstract][Full Text] [Related]
6. Vitamin E in kidney transplantation: effect of treatment with simvastatin in hypercholesterolemia.
Cantarell C; Bonal J; Sierra C; Pastor C; Lauzurica R; Capdevila L
Transplant Proc; 1995 Aug; 27(4):2222-3. PubMed ID: 7652781
[No Abstract] [Full Text] [Related]
7. Conversion to tacrolimus to ameliorate cyclosporine toxicity in kidney recipients.
Burrows L; Knight R; Genyk Y; Schwartz B; Moran V; Anand R
Transplant Proc; 1998 Aug; 30(5):2030-2. PubMed ID: 9723378
[No Abstract] [Full Text] [Related]
8. [Rhabdomyolysis caused by simvastatinin a patient following heart transplantation and cyclosporine therapy].
Blaison G; Weber JC; Sachs D; Korganow AS; Martin T; Kretz JG; Pasquali JL
Rev Med Interne; 1992; 13(1):61-3. PubMed ID: 1410877
[TBL] [Abstract][Full Text] [Related]
9. Ezetimibe is effective in the treatment of persistent hyperlipidemia of renal allograft recipients.
Savvidaki E; Koukoulaki M; Benou A; Roumeliotou M; Fourtounas C; Kalliakmani P; Papachristou E; Vlachojannis JG; Goumenos D
Clin Nephrol; 2011 Feb; 75(2):107-12. PubMed ID: 21255539
[TBL] [Abstract][Full Text] [Related]
10. Treatment of hypercholesterolemia with fluvastatin in kidney transplant patients.
Melchor JL; Gracida C
Transplant Proc; 1998 Aug; 30(5):2054. PubMed ID: 9723390
[No Abstract] [Full Text] [Related]
11. Worldwide experience with simvastatin/lovastatin.
Walker JF
Eur Heart J; 1992 Jul; 13 Suppl B():21-2. PubMed ID: 1644097
[No Abstract] [Full Text] [Related]
12. Effects of fluvastatin on hyperlipidemia after renal transplantation: influence of steroid therapy.
Austen JL; Shifrin FA; Bartucci MR; Knauss TC; Schulak JA; Hricik DE
Ann Pharmacother; 1996 Dec; 30(12):1386-9. PubMed ID: 8968448
[TBL] [Abstract][Full Text] [Related]
13. [Rhabdomyolysis in a patient treated with lovastatin and cyclosporine].
Hermida Lazcano I; Revillo Pinilla P; Nerin Sánchez C; Lechuga Durán I; Fernández López J
An Med Interna; 1997 Sep; 14(9):488. PubMed ID: 9453765
[No Abstract] [Full Text] [Related]
14. Post-transplant hyperlipidaemia: low-dose lovastatin lowers atherogenic lipids without plasma accumulation of lovastatin.
Gullestad L; Nordal KP; Forfang K; Ihlen H; Høstmark A; Berg KJ; Cheng H; Schwartz MS; Geiran O; Simonsen S
J Intern Med; 1997 Dec; 242(6):483-90. PubMed ID: 9437409
[TBL] [Abstract][Full Text] [Related]
15. Impact of fluvastatin on hyperlipidemia after renal transplantation.
Tokumoto T; Tanabe K; Ishida H; Shimmura H; Ishikawa N; Goya N; Akiba T; Toma H
Transplant Proc; 2004 Sep; 36(7):2141-4. PubMed ID: 15518777
[TBL] [Abstract][Full Text] [Related]
16. Immunosuppression with sirolimus, cyclosporyne, and prednisone in renal transplantation.
Gonzalez-Posada JM; Rodriguez AP; Pérez-Tamajón L; Hdez-Marrero D; Maceira B
Transplant Proc; 2002 Feb; 34(1):99. PubMed ID: 11959204
[No Abstract] [Full Text] [Related]
17. Frequency of myopathy in patients receiving lovastatin.
Wortmann RL; Tipping RW; Levine JG; Melin JM
Am J Cardiol; 2005 Apr; 95(8):983-5. PubMed ID: 15820170
[TBL] [Abstract][Full Text] [Related]
18. Interaction between lovastatin and cyclosporine A after heart and kidney transplantation.
Gullestad L; Nordal KP; Berg KJ; Cheng H; Schwartz MS; Simonsen S
Transplant Proc; 1999 Aug; 31(5):2163-5. PubMed ID: 10456002
[No Abstract] [Full Text] [Related]
19. Effect of variability of cyclosporine pharmacokinetics on long-term renal allograft survival.
Markell MS; Homel P; Sumrani N; Hong JH; Distant DA; Miles AM; Sommer BG; Friedman EA
Transplant Proc; 1998 Aug; 30(5):1980-2. PubMed ID: 9723360
[No Abstract] [Full Text] [Related]
20. Low-dose lovastatin in hyperlipidemic kidney graft recipients with cyclosporine A.
Traindl O; Reading S; Franz M; Falger S; Klauser R; Gisinger J; Widhalm K; Kovarik J
Transplant Proc; 1992 Dec; 24(6):2745-7. PubMed ID: 1465924
[No Abstract] [Full Text] [Related]
[Next] [New Search]
